"Q4 has to be better, right?
going to be a biotech boomer...
posted on EXEL mb ystdy:
"Despite some high profile deals, it has been a slow year for M&A because of COVID-19. We had a lot of deals in process when things shut down. We’ve done financings with conference calls, but it’s harder to do M&As when you can’t have in-person conversations for due diligence. So, during the lockdowns we put things on hold, but conducted some facility inspections using drones. Now we’re seeing a tremendous amount of pent up appetite for M&As."